January 2020

Posted Posted in Hallwang Clinic News

January 2020 – Up2Date in HER2-positive breast cancer: New therapy strategy available The FDA has granted an accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu; DS-8201) for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-her2-positive-breast-cancer

Case of Excellent Response

Posted Posted in Hallwang Clinic News

Christmas and holiday time means family time. Often, it is the only time of the year everyone can get together in the same place. Nick and his family feared that Christmas 2018 would be the last after being diagnosed with nasopharyngeal cancer in July 2018 and sepsis with multi organ failure in December 2018. When […]